Recent MSK Discoveries & Advances

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our blog, On Cancer.

and/or

331 News Items found

In the Lab

MSK Scientists Build "Armored" CAR T Cells to Smite Solid Tumors

The engineered immune cells secrete powerful drugs as a layer of defense.

MSK physician-scientist Renier Brentjens

Ask the Expert

Does Vitamin D Reduce the Risk of Getting Cancer?

Two MSK medical oncologists discuss the link between the "sunshine vitamin" and cancer.

Five people on the beach during a sunset

Announcement

FDA Approves Ivosidenib (Tibsovo®), a Targeted Drug, for Acute Myeloid Leukemia

The drug provides a new treatment option for people whose cancer has stopped responding to other therapies.

Hematologic oncologist Martin Tallman and nurse practitioner Bernadette Cuello

In the Lab

Scientists Identify Growth Signal for Metastatic Cancer "Seeds"

Targeting this signal with drugs might be one way to stop cancers from spreading.

This image shows cancer cells (white) and pericytes (green) clinging to capillaries (red). The blue dots are nuclei.

Feature

Meet the Scientists Who Engineer CAR T Cells, a Type of "Living" Immunotherapy

An immunotherapy called CAR T is transforming the treatment of certain cancers. These are the people who make it possible.

MSK cell manufacturing specialist Xiuyan Wang

Finding

Research Advances the Genetic Understanding of Pineoblastoma, a Rare Brain Cancer

The findings will lead to more accurate diagnoses and, potentially, to better treatments.

CT scans of brains

Finding

Double Jeopardy: Gene-Sequencing Test Uncovers New Clues about a Defect Seen in Many Tumors

MSK researchers have found that a genetic state in tumors called whole-genome doubling is connected with worse outcomes for people with cancer.

MSK computational biologist Barry Taylor

In the Lab

Splicing May Be an Effective Target in the Fight against Cancer

New drugs are being developed that target part of the process to make proteins.

MSK physician-scientist Omar Abdel-Wahab

Feature

New Imaging Technique Provides Snapshot of Brain Tumor Activity

A new imaging approach could shorten the time needed to determine whether a brain tumor treatment is working.

Side-by-side images of brain MRIs.

Feature

Meet the Unsung Immune Cell that Could Change Immunotherapy

A lesser-known immune cell is suddenly getting more attention in the field of cancer immunology.

NK cells attacking